Thursday, October 3, 2019

October 03, 2019 at 03:45PM RAPLIXA

Product approval information is indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oe0CIz

No comments:

Post a Comment